Cytoplasmic control of premature activation of a secreted protease zymogen: Deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype

Journal of Bacteriology

Volumn 187, Issue 5, 2005, Pages 1751-1762

  Shaw, Lindsey N ^a   Golonka, Ewa ^b   Szmyd, Grzegorz ^b   Foster, Simon J ^c   Travis, James ^a   Potempa, Jan ^a,b  

^a University of Georgia ^*  (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ENZYME PRECURSOR; LYSOSTAPHIN; MUTANT PROTEIN; PEPTIDOGLYCAN; PROTEIN SSPC; PROTEINASE; STAPHOPAIN B; STAPHOSTATIN B; UNCLASSIFIED DRUG;

ARTICLE; AUTOLYSIS; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; CULTURE MEDIUM; CYTOLYSIS; ENZYME ACTIVATION; ENZYME REGULATION; GENE DELETION; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ENGINEERING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SECRETION; STAPHYLOCOCCUS AUREUS;

BACTERIAL PROTEINS; CARRIER PROTEINS; CYTOPLASM; ENZYME ACTIVATION; ENZYME PRECURSORS; GENE EXPRESSION REGULATION, BACTERIAL; LYSOSTAPHIN; MUTAGENESIS, INSERTIONAL; MUTATION; PEPTIDOGLYCAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS;

EID: 14244266586     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.187.5.1751-1762.2005     Document Type: Article

References (70)

1. Arvidson, S., and K. Tegmark. 2001. Regulation of virulence determinants in Staphylococcus aureus. Int. J. Med. Microbiol. 291:159-170.
2. Balaban, N., and R. P. Novick. 1995. Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3′-end deletion. FEMS Microbiol. Lett. 133:155-161.
3. Beenken, K. E., J. S. Blevins, and M. S. Smeltzer. 2003. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect. Immun. 71:4206-4211.
4. Braun, P., A. de Groot, W. Bitter, and J. Tommassen. 1998. Secretion of elastinolytic enzymes and their propeptides by Pseudomonas aeruginosa. J. Bacteriol. 180:3467-3469.
5. Caiazza, N. C., and G. A. O'Toole. 2003. Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J. Bacteriol. 185:3214-3217.
6. Calander, A. M., I. M. Jonsson, A. Kanth, S. Arvidsson, L. Shaw, S. J. Foster, and A. Tarkowski. 2004. Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect. 6:202-206.
7. Campo, N., H. Tjalsma, G. Buist, D. Stepniak, M. Meijer, M. Veenhuis, M. Westermann, J. P. Muller, S. Bron, J. Kok, O. P. Kuipers, and J. D. Jongbloed. 2004. Subcellular sites for bacterial protein export. Mol. Microbiol. 53:1583-1599.
8. Chan, P., and S. J. Foster. 1998. The role of environmental factors in the regulation of virulence determinants expression in Staphylococcus aureus 8325-4. Microbiology 144:2469-2479.
9. Chan, P. F., and S. J. Foster. 1998. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J. Bacteriol. 180:6232-6241.
10. Cheung, A. L., A. S. Bayer, G. Zhang, H. Gresham, and Y. Q. Xiong. 2004. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 40:1-9.
11. Chung, C. H., H. E. Ives, S. Almeda, and A. L. Goldberg. 1983. Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases. J. Biol. Chem. 258:11032-11038.
12. Coulter, S., W. Scwan, E. Ng, M. Langhorne, H. Ritchie, S. Westbrock-Wadman, W. Hufnagle, K. Folger, A. Bayer, and C. Stover. 1998. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30:393-404.
13. Cramton, S. E., C. Gerke, N. F. Schnell, W. W. Nichols, and F. Gotz. 1999. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67:5427-5433.
14. Drapeau, G. R. 1978. Role of a metalloprotease in activation of the precursor of staphylococcal protease. J. Bacteriol. 136:607-613.
15. Dubin, G., M. Krajewski, G. Popowicz, J. Stec-Niemczyk, M. Bochtler, J. Potempa, A. Dubin, and T. A. Holak. 2003. A novel class of cysteine protease inhibitors: solution structure of staphostatin A from Staphylococcus aureus. Biochemistry 42:13449-13456.
16. Dubin, G., J. Stec-Niemczyk, T. Dylag, J. Silberring, A. Dubin, and J. Potempa. 2004. Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family. Biol. Chem. 385:543-546.
17. Dubin, G. 2002. Extracellular proteases of Staphylococcus spp. Biol. Chem. 383:1075-1086.
18. Dubin, G. 2003. Defense against own arms: staphylococcal cysteine proteases and their inhibitors. Acta Biochim. Pol. 50:715-724.
19. Emori, T., and R. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442.
20. Filipek, R., M. Rzychon, A. Oleksy, M. Gruca, A. Dubin, J. Potempa, and M. Bochtler. 2003. The staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. J. Biol. Chem. 278: 40959-40966.
21. Filipek, R., R. Szczepanowski, A. Sabat, J. Potempa, and M. Bochtler. 2004. The prostaphopain B structure: a comparison of proregion-mediated and staphostatin-mediated protease inhibition. Biochemistry 43:14306-14315.
22. Foster, S. J. 1995. Molecular characterisation and functional analysis of the major autolysin of Staphylococcus aureus. J. Bacteriol. 177:5723-5725.
23. B activity depends on RsbU in Staphylococcus aureus. J. Bacteriol. 183:1843-1852.
24. Golonka, E., R. Filipek, A. Sabat, A. Sinczak, and J. Potempa. 2004. Genetical characterization of the staphopain genes in Staphylococcus aureus. Biol. Chem. 385:1059-1067.
25. Greenbaum, D., K. F. Medzihradszky, A. Burlingame, and M. Bogyo. 2000. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7:569-581.
26. Guerout-Fleury, A. M., K. Shazand, N. Frandsen, and P. Stragier. 1995. Antibiotic-resistance cassettes for Bacillus subtilis. Gene 167:335-336.
27. 2 coordinative bond. J. Biol. Chem. 276:35087-35092.
28. Heussen, C., and E. B. Dowdle. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:196-202.
29. B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J. Bacteriol. 184:5457-5467.
30. Ji, G., R. Beavis, and R. Novick. 1995. Cell density control of staphylococcal virulence mediated by an octopeptide pheromone. Proc. Natl. Acad. Sci. USA 92:12055-12059.
31. Karlin, S., J. Theriot, and J. Mrazek. 2004. Comparative analysis of gene expression among low G+C gram-positive genomes. Proc. Natl. Acad. Sci. USA 101:6182-6187.
32. Karlsson, A., and S. Arvidson. 2002. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect. Immun. 70:4239-4246.
33. Karlsson, A., P. Saravia-Otten, K. Tegmark, E. Morfeldt, and S. Arvidson. 2001. Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect. Immun. 69:4742-4748.
34. Kemp, E., R. Sammons, A. Moir, D. Sun, and P. Setlow. 1991. Analysis of transcriptional control of the gerD spore germination gene of Bacillus subtilis 168. J. Bacteriol. 173:4646-4652.
35. Kessler, E., M. Safrin, J. K. Gustin, and D. E. Ohman. 1998. Elastase and the LasA protease of Pseudomonas aeruginosa are secreted with their propeptides. J. Biol. Chem. 273:30225-30231.
36. B in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180:4814-4820.
37. Lim, Y., M. Jana, T. T. Luong, and C. Y. Lee. 2004. Control of glucose- and NaCl-induced biofilm formation by rbf in Staphylococcus aureus. J. Bacteriol. 186:722-729.
38. Lindsay, J., and S. Foster. 1999. Interactive regulatory pathways control virulence determinant production and stability in response to the environment in Staphylococcus aureus. Mol. Gen. Genet. 262:323-331.
39. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
40. Mani, N., P. Tobin, and R. Jayaswal. 1993. Isolation and characterization of autolysis-defective mutants of Staphylococcus aureus created by Tn917-lacZ mutagenesis. J. Bacteriol. 175:1493-1499.
41. Maskalyk, J. 2002. Antimicrobial resistance takes another step forward. Can. Med. Assoc. J. 167:375.
42. Massimi, I., E. Park, K. Rice, W. Muller-Esterl, D. Sauder, and M. J. McGavin. 2003. Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. Chem. 277:41770-41777.
43. McAleese, F., E. Walsh, M. Sieprawska, J. Potempa, and T. Foster. 2001. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J. Biol. Chem. 276:29969-29978.
44. McGavin, M. J., C. Zahradka, K. Rice, and J. E. Scott. 1997. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect. Immun. 65:2621-2628.
45. Navarre, W. W., and O. Schneewind. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63:174-229.
46. Novick, R. P. 2000. Pathogenicity factors and their regulation, p. 392-407. In Gram-positive pathogens. ASM Press, Washington, D.C.
47. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
48. Oshida, T., M. Takano, M. Sugai, H. Suginaka, and T. Matsushita. 1998. Expression analysis of the autolysin gene (atl) of Staphylococcus aureus. Microbiol. Immunol. 42:655-659.
49. Pallen, M. J., and B. W. Wren. 1997. The HtrA family of serine proteases. Mol. Microbiol. 26:209-221.
50. B activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth. Infect. Immun. 69:7858-7865.
51. Park, S., and D. R. Galloway. 1998. Pseudomonas aeruginosa LasD processes the inactive LasA precursor to the active protease form. Arch. Biochem. Biophys. 357:8-12.
52. Pearson, H. 2002. 'Superbug' hurdles key drug barrier. Nature 418:469.
53. Projan, S., and R. Novick. 1997. The molecular basis of pathogenicity, p. 55-81. In The staphylococci in human disease. Churchill Livingstone, New York, N.Y.
54. Qoronfleh, M. W., and B. J. Wilkinson. 1986. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob. Agents Chemother. 29:250-257.
55. Rice, K., R. Peralta, D. Bast, J. de Azavedo, and M. McGavin. 2001. Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect. Immun. 69:159-169.
56. Robinson, J. M., J. K. Hardman, and G. L. Sloan. 1979. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J. Bacteriol. 137:1158-1164.
57. Rosch, J., and M. Caparon. 2004. A microdomain for protein secretion in gram-positive bacteria. Science 304:1513-1515.
58. Rzychon, M., A. Sabat, K. Kosowska, J. Potempa, and A. Dubin. 2003. Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases. Mol. Microbiol. 49:1051-1066.
59. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
60. Schägger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
61. Schenk, S., and R. A. Ladagga. 1992. Improved methods for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 94:133-138.
62. Shaw, L., E. Golonka, J. Potempa, and S. J. Foster. 2004. The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150:217-228.
63. Sugai, M., T. Fujiwara, K. Ohta, H. Komatsuzawa, M. Ohara, and H. Suginaka. 1997. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. J. Bacteriol. 179:4311-4318.
64. Sullivan, M., R. Yasbin, and F. Young. 1984. New shuttle vectors for Bacillus subtilis and Escherichia coli which allow rapid detection of inserted fragments. Gene 29:21-26.
65. Taguchi, S., S. Kojima, M. Terabe, Y. Kumazawa, H. Kohriyama, M. Suzuki, K. Miura, and H. Momose. 1997. Molecular phylogenetic characterization of Streptomyces protease inhibitor family. J. Mol. Evol. 44:542-551.
66. Towbin, H., T., Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-43504.
67. B is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48:1075-1087.
68. van Wely, K. H., J. Swaving, R. Freudl, and A. J. Driessen. 2001. Translocation of proteins across the cell envelope of Gram-positive bacteria. FEMS Microbiol. Rev. 25:437-454.
69. Yokoi, K., M. Kakikawa, H. Kimoto, K. Watanabe, H. Yasukawa, A. Yamakawa, A. Taketo, and K. I. Kodaira. 2001. Genetic and biochemical characterization of glutamyl endopeptidase of Staphylococcus warneri M. Gene 281:115-122.
70. Ziebandt, A. K., H. Weber, J. Rudolph, R. Schmid, D. Hoper, S. Engelmann, and M. Hecker. 2001. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 1:480-493.